Drugs / AG2001
last change Mar 2026 re-read 3 minutes ago

AG2001

Developed for
bronchitis
Investigated by
Ahn-Gook Pharmaceuticals Co.,Ltd

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT07198347 Nov 2025 → Mar 2026 overdue bronchitis Ahn-Gook Pharmaceuticals Co.,Ltd Not yet recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AG2001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT07198347 ↗
Route Oral “Oral administration, three times daily for 7 days.” NCT07198347 ↗